| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 206,533 | 266,299 | 190,246 | 435,042 | | Cost of Revenue | 161,011 | 141,845 | 156,649 | 162,003 | | | Gross Profit | 45,522 | 124,454 | 33,597 | 273,039 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 7,629 | 6,198 | 11,019 | (13,332) | | Non Recurring |
-
|
-
|
-
| 698,508 | | Others | 21,896 | 20,987 | 24,680 | 71,072 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 15,997 | 97,269 | (2,102) | (483,209) | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
|
-
| 19,867 | | Earnings Before Interest And Taxes | 122,127 | 96,148 | (2,102) | (432,768) | | Interest Expense | 28,320 | 26,366 | 21,134 | 23,231 | | Income Before Tax | 93,807 | 69,782 | (23,236) | (455,999) | | Income Tax Expense |
-
|
-
|
-
|
-
| | Minority Interest | (954) | (1,121) |
-
| 30,574 | | | | Net Income From Continuing Ops | (11,202) | 69,782 | (23,236) | (455,999) | | | Non-recurring Events | | Discontinued Operations |
-
| 62,495 |
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (14,177) | 132,277 | (23,236) | (455,999) | | Preferred Stock And Other Adjustments |
-
| 469 | (1,369) | (332) | | | Net Income Applicable To Common Shares | ($14,177) | $132,746 | ($24,605) | ($456,331) |
|
0.11% Nasdaq 
0.01%
Income Statement
